HDFS Pharmaceuticals Private Limited
About HDFS Pharmaceuticals Private Limited
Data last updated:
HDFS Pharmaceuticals Private Limited is a private limited company based in Noida, Uttar Pradesh, India. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 29 December 2022.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U51909UP2022PTC175891.
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Akash Tripathi and Dhawal Prajapati.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at E – 084 Beta – 1 Greater, Noida, Uttar Pradesh, India – 201310.
Company details
Contact details
HDFS Pharmaceuticals Private Limited's registered office is in Noida, Uttar Pradesh.
- Registered AddressE – 084 Beta – 1 Greater, Noida, Uttar Pradesh, India – 201310
- IndustryTrading, Specialty, Wholesale
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of HDFS Pharmaceuticals Private Limited
FY 2024 filings availableFinancial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ||
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ||
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | ||
| Net Profit Margin | ||
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of HDFS Pharmaceuticals Private Limited, buy the company report.
Board of directors of HDFS Pharmaceuticals Private Limited
HDFS Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Akash Tripathi | Director | 29 Dec 2022 | 3 Years 9 Months | Current |
| Dhawal Prajapati | Director | 23 Mar 2024 | 2 Years 7 Months | Current |
Legal cases
No court or tribunal cases involving HDFS Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for HDFS Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for HDFS Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
HDFS Pharmaceuticals Private Limited has 4 board changes on record since 2022: 2 appointments and 2 cessations. The latest: Surendra Kumar Tripathi ceased to be Director on 30 Mar 2025.
Frequently asked questions
HDFS Pharmaceuticals is an active private limited company based in Noida, Uttar Pradesh, India. The company works in specialty, within the trading industry. It was incorporated on 29 December 2022 (4+ years old) and is registered under CIN U51909UP2022PTC175891.
HDFS Pharmaceuticals has 2 current directors:
- Akash Tripathi - Director
- Dhawal Prajapati - Director
The latest financial statements of HDFS Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2023 are in the company report.
The CIN (Corporate Identification Number) of HDFS Pharmaceuticals is U51909UP2022PTC175891. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
HDFS Pharmaceuticals was incorporated on 29 December 2022, making it 4+ years old. It is registered with the Registrar of Companies, Kanpur.
Surendra Kumar Tripathi ceased to be Director on 30 Mar 2025. Dhawal Prajapati ceased to be Additional Director on 29 Sep 2024. Dhawal Prajapati was appointed as Director on 23 Mar 2024. HDFS Pharmaceuticals has 4 board changes on record in total.
The registered office of HDFS Pharmaceuticals is at E – 084 Beta – 1 Greater, Noida, Uttar Pradesh, India – 201310.
HDFS Pharmaceuticals operates in the trading industry, in the specialty segment.
HDFS Pharmaceuticals can be reached at its registered office: E – 084 Beta – 1 Greater, Noida, Uttar Pradesh, India – 201310.
HDFS Pharmaceuticals is registered under the jurisdiction of the Registrar of Companies (ROC), Kanpur.